Ulrica Wilderäng

AstraZeneca (Brazil) — Brazil

Medicine · Health Sciences

34h-index6.2kcitations100works9.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(24), Effects of Radiation Exposure(23), Diabetes Treatment and Management(17), Cancer survivorship and care(16), Heart Failure Treatment and Management(14)

Publications100 total

Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
New England Journal of Medicine·2025· 46 citedOpen Access
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24
Hypertension Research·2025· 5 citedOpen Access
Re-Evaluating Recurrent Events in Heart Failure Trials
Journal of the American College of Cardiology·2025· 3 citedOpen Access
BASELINE CHARACTERISTICS OF PATIENTS IN BAXHTN: A PHASE 3 TRIAL OF THE ALDOSTERONE SYNTHASE INHIBITOR BAXDROSTAT IN PATIENTS WITH UNCONTROLLED OR RESISTANT HYPERTENSION
Journal of Hypertension·2025
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials
Journal of Cardiac Failure·2024· 4 citedOpen Access
RATIONALE AND DESIGN OF PHASE 3 TRIAL FOR BAXDROSTAT, A NOVEL HIGHLY SELECTIVE ALDOSTERONE SYNTHETASE INHIBITOR
Journal of Hypertension·2024· 1 cited
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER
Journal of Cardiac Failure·2023· 9 citedOpen Access
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials
Circulation·2023· 42 citedOpen Access
Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials
NEJM Evidence·2023· 13 citedOpen Access
Intra-abdominal Surgery and Intestinal Syndromes After Pelvic Radiation Therapy
Advances in Radiation Oncology·2023Open Access
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
European Heart Journal·2023· 34 citedOpen Access
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JAMA Cardiology·2023· 18 citedOpen Access
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Journal of the American College of Cardiology·2022· 71 citedOpen Access
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan
European Journal of Heart Failure·2022· 31 citedOpen Access
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
Circulation·2022· 140 citedOpen Access
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
Journal of the American College of Cardiology·2022· 89 citedOpen Access
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
New England Journal of Medicine·2022· 2.4k citedOpen Access
Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction
Journal of the American College of Cardiology·2022· 43 citedOpen Access
Dapagliflozin for heart failure according to body mass index: the DELIVER trial
European Heart Journal·2022· 140 citedOpen Access
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
Circulation Heart Failure·2022· 112 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Gunnar Steineck(33), Scott D. Solomon(13), John J.V. McMurray(13), Rudolf A. de Boer(13), Mikhail Kosiborod(13), Sanjiv J. Shah(13), Eva Haglind(13), Johan Stranne(13), Jonas Hugosson(13), Brian Claggett(12), Adrian F. Hernandez(12), Silvio E. Inzucchi(12), Carolyn S.P. Lam(12), Felipe A. Martínez(12), Peter Wiklund(12), Muthiah Vaduganathan(11), Stefan Carlsson(11), Akshay S. Desai(10), Pardeep S. Jhund(10), Magnus Petersson(10)